LEVATUM Trademark

Trademark Overview


On Monday, November 7, 2005, a trademark application was filed for LEVATUM with the United States Patent and Trademark Office. The USPTO has given the LEVATUM trademark a serial number of 78748358. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, December 7, 2006. This trademark is owned by Pfizer Inc.. The LEVATUM trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary preparations and substances for the prevention and treatment of ocular disorders, oral diseases, disorders of the nervous system, the blood and immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the digestive system, the genitourinary system, and the reproductive system; veterinary preparations and substances for the treatment and prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations and substances for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; nutritional additives and food supplements; veterinary dental preparations in the nature of a pharmaceutical drug or vaccine for the treatment and prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; Pharmaceutical preparations for relieving teething pains and toothaches; anti-infectives; anti-bacterials; antivirals; antibiotics; antifungals; anthelminti...
levatum

General Information


Serial Number78748358
Word MarkLEVATUM
Filing DateMonday, November 7, 2005
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, December 7, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVeterinary preparations and substances for the prevention and treatment of ocular disorders, oral diseases, disorders of the nervous system, the blood and immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the digestive system, the genitourinary system, and the reproductive system; veterinary preparations and substances for the treatment and prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations and substances for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; nutritional additives and food supplements; veterinary dental preparations in the nature of a pharmaceutical drug or vaccine for the treatment and prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; Pharmaceutical preparations for relieving teething pains and toothaches; anti-infectives; anti-bacterials; antivirals; antibiotics; antifungals; anthelmintics; parasiticides; analgesics and anti-allergens, all of the foregoing for treating felines, canines, bovines, porcines, equines, rabbits, poultry, goats and sheep

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 10, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Thursday, December 7, 2006ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, December 7, 2006ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 11, 2006NON-FINAL ACTION MAILED
Wednesday, May 10, 2006NON-FINAL ACTION WRITTEN
Wednesday, May 10, 2006ASSIGNED TO EXAMINER
Thursday, November 10, 2005NEW APPLICATION ENTERED IN TRAM